Cipla Competitors and Similar CompaniesClear all
Cipla's competitors and similar companies include Biocon, Abbott India, Pfizer, Par Pharmaceutical and Dr. Reddy's Laboratories.
 Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Par Pharmaceutical Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. | ||||
Founding Date | Founding Date 1935 | Founding Date 1978 | Founding Date 1944 | Founding Date 1849 | Founding Date 1978 | Founding Date 1984 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||||
Locations | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Mumbai, IN HQ Mumbai, IN Verna, IN | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Hyderabad, IN HQ Melbourne, AU São Paulo, BR Mississauga, CA Kunshan, CN Bogotá, CO Rueil Malmaison, FR see more | |
Employees | Employees 27,764 | Employees 16,5612% increase | Employees 3,814 | Employees 81,0008% decrease | Employees 1,395 | Employees 27,0486% increase |
Financial | ||||||
Revenue (est.) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) ₹69.3b (FY, 2026) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹335.9b (FY, 2026) |
Cost of goods | Cost of goods ₹95.5b (FY, 2026) | Cost of goods ₹56.9b (FY, 2026) | Cost of goods ₹36.9b (FY, 2026) | Cost of goods $16.1b (FY, 2025) | Cost of goods N/A | Cost of goods ₹122.4b (FY, 2026) |
Gross profit | Gross profit ₹195b (FY, 2026) | Gross profit ₹115.8b (FY, 2026) | Gross profit ₹35.2b (FY, 2026) | Gross profit $46.5b (FY, 2025) | Gross profit N/A | Gross profit ₹228.2b (FY, 2026) |
Net income | Net income ₹38.7b (FY, 2026) | Net income ₹3.7b (FY, 2026) | Net income ₹15.5b (FY, 2026) | Net income $7.8b (FY, 2025) | Net income N/A | Net income ₹41.6b (FY, 2026) |
Operating ⚠ | ||||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 200 (FY, 2024) | Countries N/A | Countries 76 (FY, 2024) |
Dossiers Filed | Dossiers Filed 270 (FY, 2024) | Dossiers Filed N/A | Dossiers Filed N/A | Dossiers Filed N/A | Dossiers Filed N/A | Dossiers Filed 241 (FY, 2024) |
Drug Master Files Filed | Drug Master Files Filed 503 (FY, 2024) | Drug Master Files Filed N/A | Drug Master Files Filed N/A | Drug Master Files Filed N/A | Drug Master Files Filed N/A | Drug Master Files Filed 133 (FY, 2024) |
Manufacturing Sites | Manufacturing Sites 46 (FY, 2024) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 37 (FY, 2024) | Manufacturing Sites N/A | Manufacturing Sites N/A |
For sources of this data, please see the company profile
View Company Profiles
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View company
Abbott India
HQ
Mumbai, IN
Employees
3,814
Abbott India is a pharmaceutical company that offers medicinal drugs.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyPar Pharmaceutical
HQ
Dublin 4, IE
Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life.
View company